Volume 136, Issue 1, Pages e2 (January 2009)

Slides:



Advertisements
Similar presentations
Reduced Tumor Necrosis Factor-α and Transforming Growth Factor-β1 Expression in the Lungs of Inbred Mice that Fail to Develop Fibroproliferative Lesions.
Advertisements

Volume 132, Issue 3, Pages (March 2007)
Matrix Metalloproteinase-9 Inhibition Reduces Inflammation and Improves Motility in Murine Models of Postoperative Ileus  Beverley A. Moore, Carl L. Manthey,
Volume 142, Issue 4, Pages (April 2012)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 135, Issue 1, Pages e3 (July 2008)
Volume 132, Issue 7, Pages (June 2007)
Volume 123, Issue 5, Pages (November 2002)
Volume 138, Issue 1, Pages (January 2010)
Volume 131, Issue 3, Pages (September 2006)
Tocotrienols Induce Apoptosis and Autophagy in Rat Pancreatic Stellate Cells Through the Mitochondrial Death Pathway  Mariana Rickmann, Eva C. Vaquero,
Volume 133, Issue 6, Pages (December 2007)
Volume 142, Issue 4, Pages e6 (April 2012)
Volume 137, Issue 2, Pages e2 (August 2009)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice  Belinda Knight, Janina E.E. Tirnitz–Parker,
Volume 134, Issue 1, Pages (January 2008)
Jack C. Reidling, Nils Lambrecht, Mohammad Kassir, Hamid M. Said 
Volume 133, Issue 6, Pages (December 2007)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 134, Issue 7, Pages (June 2008)
Volume 129, Issue 5, Pages (November 2005)
Volume 138, Issue 4, Pages (April 2010)
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Volume 42, Issue 4, Pages (April 2005)
Volume 114, Issue 3, Pages (March 1998)
Volume 135, Issue 1, Pages e3 (July 2008)
Volume 133, Issue 1, Pages (July 2007)
Volume 132, Issue 1, Pages (January 2007)
Volume 142, Issue 4, Pages (April 2012)
Volume 137, Issue 3, Pages (September 2009)
Volume 132, Issue 7, Pages (June 2007)
Matrix Metalloproteinase-9 Inhibition Reduces Inflammation and Improves Motility in Murine Models of Postoperative Ileus  Beverley A. Moore, Carl L. Manthey,
Volume 151, Issue 6, Pages e3 (December 2016)
Volume 7, Issue 3, Pages (March 2008)
Volume 139, Issue 1, Pages e1 (July 2010)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 136, Issue 7, Pages (June 2009)
Volume 136, Issue 1, Pages (January 2009)
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 39, Issue 4, Pages (October 2003)
Volume 18, Issue 13, Pages (March 2017)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Volume 125, Issue 6, Pages (December 2003)
Volume 135, Issue 2, Pages e2 (August 2008)
Aurelia Lugea, Ilya Gukovsky, Anna S Gukovskaya, Stephen J Pandol 
Volume 125, Issue 6, Pages (December 2003)
Volume 135, Issue 2, Pages (August 2008)
Volume 134, Issue 4, Pages (April 2008)
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Volume 134, Issue 4, Pages (April 2008)
Volume 134, Issue 1, Pages (January 2008)
Volume 133, Issue 4, Pages (October 2007)
Volume 140, Issue 3, Pages (March 2011)
Volume 139, Issue 3, Pages e6 (September 2010)
Volume 139, Issue 2, Pages e1 (August 2010)
Volume 126, Issue 3, Pages (March 2004)
Volume 137, Issue 1, Pages e5 (July 2009)
Volume 130, Issue 7, Pages (June 2006)
Volume 138, Issue 4, Pages e2 (April 2010)
Volume 131, Issue 6, Pages (December 2006)
Volume 137, Issue 5, Pages (November 2009)
Volume 138, Issue 3, Pages e3 (March 2010)
Volume 127, Issue 3, Pages (September 2004)
Volume 138, Issue 3, Pages e5 (March 2010)
Volume 131, Issue 5, Pages (November 2006)
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

Volume 136, Issue 1, Pages 331-340.e2 (January 2009) Ethanol Exposure Depletes Hepatic Pigment Epithelium-Derived Factor, a Novel Lipid Regulator  Chuhan Chung, Christine Shugrue, Anil Nagar, Jennifer A. Doll, Mona Cornwell, Arijeet Gattu, Tom Kolodecik, Stephen J. Pandol, Fred Gorelick  Gastroenterology  Volume 136, Issue 1, Pages 331-340.e2 (January 2009) DOI: 10.1053/j.gastro.2008.09.065 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Liver biopsy specimens from patients with ethanol-induced steatosis demonstrate loss of PEDF. (A–C) H&E-stained sections from normal human liver (A). PEDF labeling in tissues from patients with chronic alcohol histories demonstrate marked macrovesicular steatosis (B) and mixed macro-/microvesicular steatosis (C) in the absence of inflammatory or fibrotic changes. (D–F) Immunohistochemical staining for PEDF (brown label) shows abundant expression in the cytoplasm of normal hepatocytes (D) with loss of expression in hepatocytes with lipid accumulation in alcoholic patients (E and F). Results are representative of 6 controls and 6 patients with ethanol-induced steatosis. (G) PEDF labeling measured by densitometry shows markedly reduced PEDF in ethanol-exposed livers (*P < .0001). Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Livers from rats on a Lieber–DeCarli diet demonstrate steatosis but no inflammation or fibrosis. (A and B) H&E-stained sections from control rat livers (A) and rats fed ethanol for 6 weeks (B). (C) Triglyceride content increased more than 2-fold in the ethanol-fed group compared with controls: 38 ± 6.9 vs 17 ± 3.9 mg TG/g liver, respectively (*P < .05). Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Ethanol feeding results in loss of PEDF, increased MMP-2 activity, and MMP-2/9-mediated degradation of PEDF in livers from 2 rodent species. (A and B) Immunohistochemistry for PEDF demonstrates abundant cytoplasmic staining in control rat livers (A, brown label), whereas ethanol feeding results in accumulation of intracellular lipids (inset, arrows) and loss of PEDF (B). (C) Immunoblotting of hepatic lysates from control and ethanol-fed pairs of rats reveal absence of hepatic PEDF levels in 3 of the 4 animals fed ethanol. β-actin loading controls shown below. (C) Zymography of hepatic lysates show expression of the fully active form of MMP-2 (62 kilodaltons) in animals in which PEDF expression is lost. The intermediate form of MMP-2 (66 kilodaltons) was included as a positive control and is converted to the fully active form in incubation buffer. In pair 3, in which there is no appreciable loss of PEDF with ethanol exposure, MMP-2 activity was not detected. (D) Loss of PEDF also occurs in a mouse model of ethanol feeding. In 2 animals in which PEDF levels could not be detected by immunoblotting, the presence of the fully active form of MMP-2 (62 kilodaltons) was detected on zymography. Ethanol feeding increased levels of the precursor form of MMP-9 (92 kilodaltons). (E) MMP-2 degrades rPEDF in vitro. Incubation of human MMP-2 (66 kilodaltons) with rPEDF results in autoactivation of MMP-2 to its fully active form (62 kilodaltons) and PEDF degradation over time. APMA, an MMP-2 activator, leads to additional PEDF degradation. (F, left) Incubation of rPEDF with control and ethanol-fed rat liver lysates reveals degradation of PEDF at 24 hours. (F, right) Degradation of rPEDF by ethanol-exposed hepatic lysates is MMP-2 dependent; addition of the specific MMP-2 inhibitor, CTT, preserves PEDF. Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Hepatic stellate cell (HSC)-derived MMP-2 degrades PEDF. (A) Primary rat HSC from days 7 and 10 after isolation exposed to ethanol 50 mmol/L did not show increased MMP-2/-9 activity as assessed by zymography. (B) Conditioned medium (CM) from HSC-T6 demonstrate increased MMP-2 levels with immunoblotting (left), enhanced MMP-2 activity (center), and a reciprocal decrease in PEDF expression (right) with acute ethanol exposure. (C) Incubation with the specific MMP-2/9 inhibitor, CTT 50 μmol/L, results in a nearly 3-fold increase in PEDF signal from HSC-T6 (left), indicating that PEDF is secreted from these cells and that its levels are MMP-2 dependent. CTT (10–100 μmol/L) causes a concentration-dependent increase in PEDF levels in cultured rat hepatic stellate cells (right). Coomassie stain demonstrated equivalent protein loading. Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 In situ zymography (ISZ) reveals gelatinase activity in livers from ethanol-fed mice. (A and D) Representative phase (A) and corresponding ISZ (D) image of control livers show uniform green stain consistent with lack of gelatinase activity. (B and E) Phase image (B) shows abundant lipid accumulation around a central vein. ISZ image (E) shows gelatin digestion in areas overlying hepatocyte steatosis (asterisks) and diminished but preserved gelatin staining in a cuff of hepatocytes without steatosis (arrowheads). (C) Low-power ISZ image illustrates discrete regions of gelatin degradation that correlate to areas with the most lipid accumulation. (F) Restricted areas of gelatin digestion corresponding to the perisinusoidal space (arrows) occur in areas in which hepatocyte steatosis is less evident. Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 HSC activation occurs in ethanol-induced hepatic steatosis and in PEDF null livers. (A–D) Labeling for α-smooth muscle actin (α-SMA) in control rat livers was confined to vascular structures (A, low power and C, high power). α-SMA labeling (B, brown stain and D, arrows) in livers from ethanol-fed rats was consistent with HSC activation. (E) Magnified image of ethanol-fed hepatocytes reveals intracellular lipid accumulation. (F and G) α-SMA labeling was prominent in PEDF null livers (G, arrow) compared with age-matched controls (F). Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Figure 7 Addition of rPEDF to PEDF-null hepatocytes in vitro reduces TG content. (A) Adding rPEDF to isolated wild-type hepatocytes had no effect on TG content either in the absence or presence of ethanol. (B) Restoring PEDF to null hepatocytes significantly (*P = .001) reduced TG content compared with controls. There was a trend (P = .09) toward increased TG content with ethanol exposure in null hepatocytes. Adding rPEDF to ethanol-exposed hepatocytes significantly (**P = .004) decreased TG content. Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions

Supplementary Figure 1 Semiquantitative RT-PCR analysis reveals stable hepatic PEDF gene expression, whereas MMP-2 and -9 expression are increased with ethanol feeding. (A) Ethanol-exposed mouse livers resulted in unchanged PEDF expression compared with control tissues (P = NS). MMP-2 and -9 expression levels were both significantly increased by ethanol feeding (*P < .05). TIMP1 expression was increased (*P < .05), whereas no significant differences in TIMP2 or MT1-MMP expression levels were detected. (B) Corresponding densitometry. Gastroenterology 2009 136, 331-340.e2DOI: (10.1053/j.gastro.2008.09.065) Copyright © 2009 AGA Institute Terms and Conditions